The review found no eligible studies for this question.
The review found no eligible studies for this question.
Prostaglandin alone may leads to higher failure to achieve complete abortion compared with combined regimen (low certainty).
The review found no eligible studies for this question.
Prostaglandin alone showed no clear difference in nausea compared with combined regimen (low certainty).
Prostaglandin alone showed no clear difference in women's dissatisfaction with the procedure compared with combined regimen (low certainty).
Prostaglandin alone showed no clear difference in blood transfusion compared with combined regimen (low certainty).
Sublingual misoprostol alone showed no clear difference in failure to achieve complete abortion compared with vaginal misoprostol alone (low certainty).
Sublingual misoprostol alone showed no clear difference in nausea compared with vaginal misoprostol alone (low certainty).
Sublingual misoprostol alone may leads to lower women's dissatisfaction with the procedure compared with vaginal misoprostol alone (low certainty).
The review found no eligible studies for this question.
It is very uncertain whether sublingual misoprostol alone changes blood transfusion compared with vaginal misoprostol alone (very low certainty).
Misoprostol 800 µg plus mifepristone 200 mg probably leads to lower failure to achieve complete abortion compared with misoprostol 400 µg plus mifepristone 200 mg (moderate certainty).
Misoprostol 800 µg plus mifepristone 200 mg showed no clear difference in nausea compared with misoprostol 400 µg plus mifepristone 200 mg (moderate certainty).
Misoprostol 800 µg plus mifepristone 200 mg probably leads to lower women's dissatisfaction with the procedure compared with misoprostol 400 µg plus mifepristone 200 mg (moderate certainty).
The review found no eligible studies for this question.
Certolizumab pegol probably leads to lower failure to maintain clinical remission at week 26(1 RCT, 428… compared with placebo (moderate certainty).
Certolizumab pegol probably leads to lower failure to maintain clinical response at week 26(1 RCT, 428… compared with placebo (moderate certainty).
Certolizumab pegol showed no clear difference in serious adverse events during remission maintenance treatment(1 RCT,… compared with placebo (low certainty).
Aspirin showed no clear difference in graft thrombosis (28 days to 18 months) compared with placebo (low certainty).